Drupal.behaviors.print = function(context) {window.print();window.close();}>
Affymetrix Posts 2 Percent Q1 Revenue Growth
April 22, 2010
Affymetrix Posts 2 Percent Q1 Revenue Growth
A strong quarter for Affy's product sales was offset by lower service revenues.
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Affymetrix's eBio Business Moving FlowCytomix Assays to Luminex Platform, Planning New Product Combinations
April 2, 2013 / BioArray News
Affy Files CytoScan with FDA, Plans 'Aggressive' Marketing Campaign to Grow Cyto Business
February 19, 2013 / BioArray News
After 'Pivotal' 2012, Affy Looks to CytoScan, Axiom Genotyping Products to Drive Future Growth
February 5, 2013 / BioArray News
Affymetrix's Q4 Revenues Shoot up 29 Percent on eBioscience Contribution
February 1, 2013 / GenomeWeb Daily News
Affy Sees Opportunities for New 384-Sample Axiom Genotyping Product in Ag, Disease Research Markets
January 22, 2013 / BioArray News